“I want to be remembered as the kid who went down fighting and didn’t really lose.”
ZACH SOBIECH
Treatments for osteosarcoma, the cancer that took Zach too soon, haven’t improved in decades. Zach wanted his legacy to change that. 100% of all donations to the Zach Sobiech Osteosarcoma fund go to research for better treatments for this deadly cancer.
Current total raised:
Your donation will help fund research for better treatments for kids with osteosarcoma.
Your Support Funds Groundbreaking Research
8 Seed Grants Funded
Promising researchers often struggle to get funding to study rare diseases like osteosarcoma, but Zach’s Fund has helped bridge that gap by funding 8 potentially groundbreaking projects.
See Project List
National Clinical Trial
Five years after Zach’s passing, researcher Branden Moriarty opens a clinical trial to test a new drug to treat osteosarcoma.
Read More
A Cure in the Making
Researcher Beau Webber has an idea for how to treat osteosarcoma more effectively – and he isn’t afraid to use the word “cure” to describe it.
Read More
The Great Minds Making it Happen
Hear from leading osteosarcoma researchers, including Zach’s own doctor, about the future of research for this rare disease.
Watch the Video
Join Zach's Movement
SHOW YOUR SUPPORT FOR BETTER TREATMENTS AND CURES FOR KIDS FIGHTING CANCER

PANTS SHIRT
Zach's "Pants" shirt, as seen in the movie "Clouds," was one of his favorites. Buy your own today - 100% of the proceeds will benefit Zach's Fund.

ROGER SHIRT
This shirt is inspired by Zach and Amy's musings about getting a horse named Roger. Purchase yours and 100% of the proceeds will benefit Zach's Fund.
Help us further zach's legacy
SPREAD THE WORD
Help us share Zach’s story. Here is a link to images, videos and resources you can share.
Move this research forward with data
Osteosarcoma researchers need more data to continue to develop better, safer treatments. If you or a loved one has osteosarcoma, click here to explore how you can participate in research studies that will fuel future breakthroughs.